Retina

Study finds lipid-lowering agents may reduce diabetic retinopathy progression

The use of lipid-lowering agents, particularly statins and PCSK9 inhibitors, is associated with a reduced risk of diabetic retinopathy progression in patients with type 2 diabetes, suggesting these treatments may be beneficial in managing this complication, according to a study. In this retrospective review, the medical records from adults with...